Federal law regulates specific programs and legal issues; it does not impose one universal testing rule on all private employers. The correct framework begins with who the employer is, what work is performed, and why the test is being required.
Federal employee testing
Executive Order 12564 and related statutes establish the federal drug-free-workplace program. HHS Mandatory Guidelines govern authorized specimens, panels, cutoffs, collection, certified laboratories, MRO review, and quality requirements. Agency plans identify testing-designated positions and test reasons.
DOT-regulated transportation
49 CFR Part 40 establishes common procedures for drug and alcohol testing in covered transportation industries. Operating-agency rules from FMCSA, FAA, FRA, FTA, PHMSA, and USCG identify the covered functions and required tests. Part 40 controls collectors, forms, laboratories, MROs, refusals, split specimens, confidentiality, and return-to-duty procedures.
See Regulated and Safety-Sensitive Industries.
Federal contractors and grantees
The Drug-Free Workplace Act requires covered contractors and grantees to maintain specified drug-free-workplace measures. Current federal acquisition rules use FAR 52.226-7 for covered contracts. Requirements include a policy statement, awareness program, conviction notice, and defined employer response. The Act does not by itself require universal employee drug testing.
Americans with Disabilities Act
The ADA does not treat a test for current illegal drug use as a medical examination and does not protect current illegal use when action is based on that use. It can protect people with a history of addiction or who are in recovery and not currently using illegally. Alcohol testing is a medical examination, and a lawful prescription revealed by a test can create disability-discrimination risk if misunderstood.
OSHA and post-incident testing
OSHA does not categorically prohibit post-incident testing. It prohibits retaliation for reporting a work-related injury or illness. Testing under federal or state law, random testing, and testing used to evaluate a genuine root cause are generally distinct from punitive testing imposed merely because an employee reported an injury.
FMLA, Title VII, and labor law
Eligible FMLA leave may cover treatment for a substance-use disorder by a healthcare provider, though absence caused by use itself is treated differently. Title VII requires neutral, nondiscriminatory application. In unionized workplaces, testing policies and consequences may be mandatory subjects of bargaining under the NLRA, subject to the interaction with any nonwaivable regulatory requirement.
Federal confidentiality rules
Part 40 limits disclosure of DOT drug-and-alcohol records. Federal employee programs have their own confidentiality provisions. Clinical substance-use-disorder treatment records may be subject to 42 CFR Part 2, but an ordinary workplace test is not automatically a Part 2 record. HIPAA applies based on who holds and discloses the information, not simply because the result is medical.
Federal versus state law
A federally required test may preempt a conflicting state restriction for the covered function, but federal coverage should not be stretched to unrelated employees or company tests. Employers often need two clearly separated programs: a federal program for covered workers and a state-compliant nonfederal program for others.
Sources
- SAMHSA: Federal Laws and Regulations
- U.S. DOT: 49 CFR Part 40
- Acquisition.gov: FAR 52.226-7 Drug-Free Workplace
- EEOC: ADA Technical Assistance Manual
- OSHA: Post-Incident Testing Clarification
Legal review: October 29, 2026.